European Archives - Page 22 of 1235 - European Medical Journal

Delgocitinib Shows Promise for Face and Neck Atopic Dermatitis

Delgocitinib ointment could be an effective and safe option for patients with face or neck atopic dermatitis (AD) who are concerned about the side effects of topical steroids or tacrolimus

Nonviral Gene Therapy Shows Promise for Age-Related Heart Disease

Nonviral gene therapy to boost brown fat molecule reverses age-related heart dysfunction in animal studies.

Esketamine Reduces Catheter-Related Bladder Discomfort After Ureteroscopy

The present study assessed the efficacy of sub-anaesthetic esketamine for CRBD prevention in patients undergoing ureteroscopic lithotripsy.

New Model Maps Pathways Driving Severe Asthma Exacerbation Risk

A registry-based analysis using Bayesian modelling has mapped the pathways linking biomarkers, lung function, and comorbidities to severe asthma exacerbation risk.

Most Patients with Chronic Pain Stop Medical Cannabis Within a Year, Study Shows

Over half of chronic pain patients discontinue medical cannabis within a year, highlighting need for individualised care.

New Test Predicts Leukaemia Relapse More Accurately

A new study has shown that a leukaemia stem cell (LSC)-based test may outperform traditional methods in predicting relapse in acute myeloid leukaemia (AML) patients after stem cell transplant…

Gut Microbiota Shapes Immune Pathways in Allergic Asthma

Against this backdrop, the gut–lung axis has emerged as a persuasive framework for understanding disease heterogeneity.

Air Pollution Exposure Linked to Fibrosis in Older Patients with MASLD

Emerging evidence also implicates air pollution in metabolic disorders common in later life, including dyslipidaemia, weight gain and impaired glucose homeostasis.

Study Finds JAK Inhibitors May Weaken T Cell Response to COVID-19 Vaccination

A new study reveals that rheumatic patients on JAK inhibitors have weaker T cell responses to SARS-CoV-2 vaccination compared to those on TNF inhibitors.

Age Affects Second Cancer Risk After Radioactive Iodine Treatment

A large US study has found that the risk of developing second primary cancers after radioactive iodine treatment for differentiated thyroid cancer varies by age group.